NEOPROGEN
NeoProgen is a therapeutics company that focuses on advancing neonatal cardiac progenitor cells. The company specializes in the fields of biotechnology and cardiac therapy. NeoProgen was founded in 2018 and headquartered in Maryland, United States.
NEOPROGEN
Industry:
Therapeutics
Founded:
2018-09-28
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.neoprogen.com
Total Employee:
1+
Status:
Active
Contact:
410-874-0055
Email Addresses:
[email protected]
Total Funding:
1.5 M USD
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
TEDCO
TEDCO investment in Seed Round - NeoProgen
UM Ventures
UM Ventures investment in Seed Round - NeoProgen
(Momentum Fund) University System of Maryland
(Momentum Fund) University System of Maryland investment in Seed Round - NeoProgen
Official Site Inspections
http://www.neoprogen.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
